Home/Pipeline/Factor VIII

Factor VIII

Hemophilia A

ApprovedCommercial

Key Facts

Indication
Hemophilia A
Phase
Approved
Status
Commercial
Company

About Tiantan Bio

Tiantan Bio is a major player in China's biopharmaceutical sector, with a core focus on plasma-derived therapeutics and vaccines. As part of the Sinopharm Group ecosystem, it benefits from significant scale and strategic importance in public health. The company leverages its extensive plasma collection network and manufacturing capabilities to serve the large domestic market, with a pipeline that includes both biosimilars and novel biological products.

View full company profile